Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer

被引：0
|
作者：
Lin Ding
Hui Jiang
Qiangwei Li
Qiushuang Li
Tian-Tian Zhang
Limeng Shang
Bin Xie
Yaling Zhu
Keshuo Ding
Xuanming Shi
Tao Zhu
Yong Zhu
机构：
[1] Anhui Medical University,Department of Pathophysiology, School of Basic Medical Sciences
[2] the First Affiliated Hospital of Anhui Medical University,Department of Anesthesiology
[3] Anhui Medical University,School of Basic Medical Sciences
[4] University of Science and Technology of China,Department of Oncology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine
[5] Anhui Medical University,Department of Pathology, School of Basic Medicine
[6] University of Science and Technology of China,Key Laboratory of Immune Response and Immunotherapy, Division of Life Sciences and Medicine
[7] Shenzhen Bay Laboratory,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 43卷
关键词：
Cancer stem cell; Breast cancer; Ropivacaine; GGT1; NF-κB signaling pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer
    Ding, Lin
    Jiang, Hui
    Li, Qiangwei
    Li, Qiushuang
    Zhang, Tian-Tian
    Shang, Limeng
    Xie, Bin
    Zhu, Yaling
    Ding, Keshuo
    Shi, Xuanming
    Zhu, Tao
    Zhu, Yong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [2] Mechanisms of acquired resistance to AKT inhibitor capivasertib in AKT1 mutant patient derived breast cancer models
    Mearns, Sarah
    Pearson, Alex
    Sim, Li-Xuan
    Cutts, Rosalind
    Sritharan, Prithika
    Shah, Heena
    Gulati, Aditi
    Williamson, Stuart
    Barry, Simon
    De-Bruin, Elza
    Turner, Nicholas C.
    CANCER RESEARCH, 2024, 84 (07)
  • [3] Akt1 governs breast cancer progression in vivo
    Ju, Xiaoming
    Katiyar, Sanjay
    Wang, Chenguang
    Liu, Manran
    Jiao, Xuanmao
    Li, Shengwen
    Zhou, Jie
    Turner, Jacob
    Lisanti, Michael P.
    Russell, Robert G.
    Mueller, Susette C.
    Ojeifo, John
    Chen, William S.
    Hay, Nissim
    Pestell, Richard G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (18) : 7438 - 7443
  • [4] Breast cancer - AKT1 wears many hats
    Seton-Rogers, Sarah
    NATURE REVIEWS CANCER, 2007, 7 (06) : 407 - 407
  • [5] AKT1 Transcriptomic Landscape in Breast Cancer Cells
    George, Bijesh
    Gui, Bin
    Raguraman, Rajeswari
    Paul, Aswathy Mary
    Nakshatri, Harikrishna
    Pillai, Madhavan Radhakrishna
    Kumar, Rakesh
    CELLS, 2022, 11 (15)
  • [6] SUMOylation regulates AKT1 activity
    C F de la Cruz-Herrera
    M Campagna
    V Lang
    J del Carmen González-Santamaría
    L Marcos-Villar
    M S Rodríguez
    A Vidal
    M Collado
    C Rivas
    Oncogene, 2015, 34 : 1442 - 1450
  • [7] SUMOylation regulates AKT1 activity
    de la Cruz-Herrera, C. F.
    Campagna, M.
    Lang, V.
    del Carmen Gonzalez-Santamaria, J.
    Marcos-Villar, L.
    Rodriguez, M. S.
    Vidal, A.
    Collado, M.
    Rivas, C.
    ONCOGENE, 2015, 34 (11) : 1442 - 1450
  • [8] Clinical value of isoform-specific detection and targeting of AKT1, AKT2 and AKT3 in breast cancer
    Perez-Tenorio, Gizeh
    Karlsson, Elin
    Stal, Olle
    BREAST CANCER MANAGEMENT, 2014, 3 (05) : 409 - 421
  • [9] Akt1 regulates melanoma metastasis to lungs
    Xie, Yi
    Yi, Xin
    Morris, Katherine
    Chen, Juhua
    CANCER RESEARCH, 2009, 69
  • [10] Abnormally elevated ubiquilin-1 expression in breast cancer regulates metastasis and stemness via AKT signaling
    Feng, Xiaoyue
    Cao, Anna
    Qin, Tao
    Zhang, Qingqing
    Fan, Shujun
    Wang, Bo
    Song, Bo
    Yu, Xiaotang
    Li, Lianhong
    ONCOLOGY REPORTS, 2021, 46 (05)
12345